| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1From the Department of Ophthalmology, Ludwig-Maximilians-University, Munich, Germany; the 3Department of Ophthalmology, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, Université Paris, Paris, France; and the 4Institute of Astronomy, Swiss Federal Institute of Technology, Zürich, Switzerland.
PURPOSE. To evaluate the absorption spectrum and osmolarity of three currently used indocyanine green (ICG) products at different concentrations and with different solvent media.
METHODS. The absorption spectrum and osmolarity of three different ICG products (Pulsion, Munich, Germany; Akorn, Buffalo Grove, IL; and Laboratoires SERB, Paris, France) were analyzed. Each ICG was further diluted with balanced salt solution or glucose 5%. Four different concentrations were evaluated: 0.005%, 0.0025%, 0.001%, and 0.00025%. ICG (Pulsion) diluted in viscoelastic material (Healon; Pharmacia, Stockholm, Sweden) was analyzed at a concentration of 0.0025%. The following parameters were measured: absorption spectrum between 400 and 1000 nm, osmolarity, and the emission spectrum of the light source of a commonly used vitrectomy machine (Megatron; Geuder, Heidelberg, Germany).
RESULTS. Independent from the manufacturer, concentrations of 0.005%, 0.0025%, and 0.001% ICG diluted in balanced salt solutions (BSS and BSS Plus; Alcon Pharmaceuticals, Fort Worth, TX) and glucose 5% showed two maxima, one at approximately 700 nm and a second one at 780 nm. There was an increase from zero to maximum absorption between 600 and 700 nm and a return to zero between 800 and 900 nm. The absorption band of ICG diluted in the viscoelastic material was similar to the saline solution (BSS or BSS Plus)-diluted ICG. At lower concentrations of 0.001% or 0.00025%, the peak at 700 nm decreased, forming a shoulder in the curve, whereas the peak at 780 nm remained stable. Osmolarity was in the range of 302 to 313 mOsM for BSS Plus-diluted ICG. When glucose 5% was used for ICG dilution, absorption between 600 and 700 nm decreased, and osmolarity was lower (between 292 and 298 mOsM). The light source emission was between 380 and 760 nm.
CONCLUSIONS. Dilution of ICG using the balanced salt solutions BSS or BSS Plus resulted in a steep increase of absorption starting at 600 nm. In clinical practice, there is an overlap between the absorption band of ICG and the emission curve of the light source, resulting in a possible photosensitizing effect, especially at higher ICG concentrations. This effect becomes less likely with decreasing ICG concentrations or when glucose 5% is used as a solvent medium.
This article has been cited by other articles:
|
|
 |
|
  E. d. P. F. Costa, E. B. Rodrigues, M. E. Farah, E. Dib, F. Penha, O. Magalhaes Jr, B. A. Furlani, A. A. S. Lima Filho, A. de Miranda, and M. Maia Vital Dyes and Light Sources for Chromovitrectomy: Comparative Assessment of Osmolarity, pH, and Spectrophotometry Invest. Ophthalmol. Vis. Sci., January 1, 2009; 50(1): 385 - 391. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Thaler, C. Haritoglou, T. J. Choragiewicz, A. Messias, A. Baryluk, C. A. May, R. Rejdak, M. Fiedorowicz, E. Zrenner, and F. Schuettauf In Vivo Toxicity Study of Rhodamine 6G in the Rat Retina Invest. Ophthalmol. Vis. Sci., May 1, 2008; 49(5): 2120 - 2126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J A Cardillo, R Jorge, R A Costa, S M T Nunes, D Lavinsky, B D Kuppermann, A C Tedesco, and M E Farah Experimental selective choriocapillaris photothrombosis using a modified indocyanine green formulation Br. J. Ophthalmol., February 1, 2008; 92(2): 276 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Beutel, G. Dahmen, A. Ziegler, and H. Hoerauf Internal Limiting Membrane Peeling With Indocyanine Green or Trypan Blue in Macular Hole Surgery: A Randomized Trial Arch Ophthalmol, March 1, 2007; 125(3): 326 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H K F Yip, T Y Y Lai, K-F So, and A K H Kwok Retinal ganglion cells toxicity caused by photosensitising effects of intravitreal indocyanine green with illumination in rat eyes Br. J. Ophthalmol., January 1, 2006; 90(1): 99 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Haritoglou, A. Yu, W. Freyer, S. G. Priglinger, C. Alge, K. Eibl, C. A. May, U. Welge-Luessen, and A. Kampik An Evaluation of Novel Vital Dyes for Intraocular Surgery Invest. Ophthalmol. Vis. Sci., September 1, 2005; 46(9): 3315 - 3322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ikagawa, M. Yoneda, M. Iwaki, Z. Isogai, K. Tsujii, R. Yamazaki, T. Kamiya, and M. Zako Chemical Toxicity of Indocyanine Green Damages Retinal Pigment Epithelium Invest. Ophthalmol. Vis. Sci., July 1, 2005; 46(7): 2531 - 2539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A K H Kwok, T Y Y Lai, C-K Yeung, Y-S Yeung, W W Y Li, and S W Chiang The effects of indocyanine green and endoillumination on rabbit retina: an electroretinographic and histological study Br. J. Ophthalmol., July 1, 2005; 89(7): 897 - 900. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Haritoglou, S. Priglinger, A. Gandorfer, U. Welge-Lussen, and A. Kampik Histology of the Vitreoretinal Interface after Indocyanine Green Staining of the ILM, with Illumination Using a Halogen and Xenon Light Source Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1468 - 1472. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T L Jackson Indocyanine green accused Br. J. Ophthalmol., April 1, 2005; 89(4): 395 - 396. [Full Text] [PDF]
|
|
|
|
|
|
J Hillenkamp, P Saikia, F Gora, H G Sachs, C P Lohmann, J Roider, W Baumler, and V-P Gabel Macular function and morphology after peeling of idiopathic epiretinal membrane with and without the assistance of indocyanine green Br. J. Ophthalmol., April 1, 2005; 89(4): 437 - 443. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. Jackson, B. Vote, B. C. Knight, A. El-Amir, M. R. Stanford, and J. Marshall Safety Testing of Infracyanine Green Using Retinal Pigment Epithelium and Glial Cell Cultures Invest. Ophthalmol. Vis. Sci., October 1, 2004; 45(10): 3697 - 3703. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kanda, A. Uemura, T. Yamashita, H. Kita, K. Yamakiri, and T. Sakamoto Visual Field Defects After Intravitreous Administration of Indocyanine Green in Macular Hole Surgery Arch Ophthalmol, October 1, 2004; 122(10): 1447 - 1451. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-D. Ho, H.-C. Chen, S.-N. Chen, and R. J.-F. Tsai Reduction of Indocyanine Green-Associated Photosensitizing Toxicity in Retinal Pigment Epithelium by Sodium Elimination Arch Ophthalmol, June 1, 2004; 122(6): 871 - 878. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Iriyama, S. Uchida, Y. Yanagi, Y. Tamaki, Y. Inoue, K. Matsuura, K. Kadonosono, and M. Araie Effects of Indocyanine Green on Retinal Ganglion Cells Invest. Ophthalmol. Vis. Sci., March 1, 2004; 45(3): 943 - 947. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gandorfer, M. Rohleder, C. Sethi, D. Eckle, U. Welge-Lussen, A. Kampik, P. Luthert, and D. Charteris Posterior Vitreous Detachment Induced by Microplasmin Invest. Ophthalmol. Vis. Sci., February 1, 2004; 45(2): 641 - 647. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
